Personalized management of differentiated thyroid cancer in real life–practical guidance from a multidisciplinary panel of experts
A Campennì, D Barbaro, M Guzzo, F Capoccetti… - Endocrine, 2020 - Springer
Purpose The standard of care for differentiated thyroid carcinoma (DTC) includes surgery,
risk-adapted postoperative radioiodine therapy (RaIT), individualized thyroid hormone …
risk-adapted postoperative radioiodine therapy (RaIT), individualized thyroid hormone …
Diagnostic performance of 2-[18F]FDG PET/CT in recurrent differentiated thyroid cancer and elevated antithyroglobulin antibodies: an updated systematic review and …
Purpose This updated systematic review and bivariate meta-analysis aimed to investigate
the diagnostic performance of 2-[18F] FDG PET/CT for the detection of recurrent disease in …
the diagnostic performance of 2-[18F] FDG PET/CT for the detection of recurrent disease in …
F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis
T Haslerud, K Brauckhoff, L Reisæter… - Acta …, 2016 - journals.sagepub.com
Background Positron emission tomography (PET) with fluor-18-deoxy-glucose (FDG) is
widely used for diagnosing recurrent or metastatic disease in patients with differentiated …
widely used for diagnosing recurrent or metastatic disease in patients with differentiated …
The Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated …
JI Bang, S Park, K Kim, Y Seo, A Chong, CM Hong… - Thyroid, 2023 - liebertpub.com
Background: The objective of this study is to evaluate the diagnostic accuracy of 18F-
fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in …
fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in …
Diagnostic performance of PET in thyroid cancer with elevated anti-Tg Ab
SJ Kim, SW Lee, K Pak… - Endocrine-Related …, 2018 - erc.bioscientifica.com
We aimed to explore the role of the diagnostic accuracy of F-18 fluorodeoxyglucose positron
emission tomography/computed tomography (PET/CT) for the detection of recurrent and/or …
emission tomography/computed tomography (PET/CT) for the detection of recurrent and/or …
The role of 18F-FDG PET/CT in the follow-up of well-differentiated thyroid cancer with negative thyroglobulin but positive and/or elevated antithyroglobulin antibody
Y Liu - Nuclear Medicine Communications, 2016 - journals.lww.com
Thyroglobulin measurement is the most sensitive and important indicator of persistent and/or
recurrent disease in the follow-up of well-differentiated thyroid cancer (DTC) after total …
recurrent disease in the follow-up of well-differentiated thyroid cancer (DTC) after total …
Correlation between metabolic uptake of F-18-FDG-PET/computed tomography and thyroglobulin level in differentiated thyroid cancer patients with suspected …
HAA Askar, RM Farghali, MA Mekkaway… - Nuclear Medicine …, 2023 - journals.lww.com
Objective Our objective is to determine if there is correlation between serum thyroglobulin
and SUVmax of the main lesion detected in F18-FDG-PET/CT scan, in differentiated thyroid …
and SUVmax of the main lesion detected in F18-FDG-PET/CT scan, in differentiated thyroid …
FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer …
S Nourbakhsh, Y Salehi, S Farzanehfar… - Nuklearmedizin …, 2024 - thieme-connect.com
Purpose The role of fibroblast activation protein inhibitor (FAPI) PET CT scan is not well
documented in papillary thyroid cancer (PTC) patients. Patients with radioiodine refractory …
documented in papillary thyroid cancer (PTC) patients. Patients with radioiodine refractory …
Diagnostic Performance of 18F-FDG PET/CT in Papillary Thyroid Carcinoma with Negative 131I-WBS at first Postablation, Negative Tg and Progressively Increased …
ZL Qiu, WJ Wei, CT Shen, HJ Song, XY Zhang… - Scientific Reports, 2017 - nature.com
Differentiated thyroid cancer (DTC) patients with negative serum thyroglobulin (Tg), negative
131I whole–body scintigraphy (131I-WBS) at first post-ablation and progressively increased …
131I whole–body scintigraphy (131I-WBS) at first post-ablation and progressively increased …
Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody
Q Jia, Z Meng, K Xu, X He, J Tan, G Zhang, X Li… - Scientific reports, 2017 - nature.com
Serum thyroglobulin (Tg) is the main post-operative tumor biomarker for patients with
differentiated thyroid cancer (DTC). However, the presence of thyroglobulin antibodies …
differentiated thyroid cancer (DTC). However, the presence of thyroglobulin antibodies …